Preparation method for pramipexole preparation

A technology of pramipexole and preparations, applied in the field of pramipexole preparations and its preparation, can solve the problems of increased hygroscopicity and affecting the storage stability of finished preparations, and achieve low hygroscopicity, strong compressibility, and good storage stability Effect

Active Publication Date: 2012-11-14
ZHEJIANG JINGXIN PHARMA
View PDF6 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Most of these substances have good water absorption and swelling properties, so they will also increase the hygroscopicity of the product, thereby affecting the storage stability of the finished preparation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for pramipexole preparation
  • Preparation method for pramipexole preparation
  • Preparation method for pramipexole preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] prescription:

[0052]

[0053]

[0054] Preparation: Weigh 4kg of maltodextrin into a stainless steel bucket, add 20kg of purified water, stir to dissolve; weigh 0.1kg of pramipexole hydrochloride in batches, add it to the prepared maltodextrin aqueous solution, and stir to obtain a clear solution; Pour batch amounts of mannitol, pregelatinized starch and microcrystalline cellulose into a high-speed wet granulator and mix them; then add pramipexole hydrochloride maltodextrin solution for granulation; the granules are transferred to a fluidized bed Drying, set the inlet air temperature to 70°C, take samples during the process, control the drying weight loss to be less than 2.0% (background temperature: 105°C); pass the dry granules through a 20-mesh sieve for granulation, then add additional silicon dioxide and magnesium stearate, mix Uniform; use 8*5mm ellipse flat slope punching plain tablet, theoretical tablet weight 102mg.

[0055] Sampling the intermediate, ...

Embodiment 2

[0059] prescription:

[0060]

[0061]

[0062] Note: Prescription B comes from the background technology WO2008122638 and does not belong to the present invention. It is used as a comparative example here to compare and investigate the moisture absorption of prescription C.

[0063] Place the tablets prepared by prescription B and prescription C at 25°C and 75% relative humidity, and measure the moisture absorption weight gain at each sampling point. The results are shown in Table 2:

[0064] Table 2 Investigation of moisture absorption

[0065]

[0066] The results of the moisture absorption test show that the sheet prepared according to the present invention has a lower degree of moisture absorption.

[0067] The pramipexole hydrochloride tablets of prescription B and prescription C were packaged in aluminum and plastic, and placed under the conditions of 60°C / 75% relative humidity and 40°C / 75% relative humidity for 4 weeks, and the content of the samples and rela...

Embodiment 3

[0080] prescription:

[0081]

[0082]

[0083] Preparation: Weigh the batch amount of pramipexole hydrochloride and add it to the prepared hydroxypropyl cellulose 50% ethanol solution, stir to dissolve; the batch amount of mannitol, pregelatinized starch and microcrystalline cellulose are granulated at high speed Mix in the machine; add hypromellose ethanol solution containing pramipexole hydrochloride for granulation; transfer the granules to a fluidized bed for drying, set the inlet air temperature at 60°C until the weight loss on drying is less than 2.0% (background temperature 105°C) ;Sizing the granules, then adding the extra micro-powdered silica gel and magnesium stearate, and mixing; adopting a φ6.5mm circular shallow concave punching plain tablet, the theoretical tablet weight is 100mg.

[0084] Vegetarian tablets at 0’HARA Coating on high-efficiency coating machine. Set the air inlet temperature to 60°C, and coat to a weight gain of 3.0%.

[0085] Sampling...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pramipexole preparation which comprises pramipexole or a medicinal salt thereof which accounts for 0.05 to 1.5% of the total weight of the preparation and is used as an active component, microcrystalline cellulose and pregelatinized starch, wherein a weight ratio of microcrystalline cellulose and pregelatinized starch is 1:1 to 1: 5. The invention also relates to a preparation method for the pramipexole preparation. The preparation prepared by using the preparation method has low hygroscopicity and is beneficial for storage; and the preparation method has good production feasibility and is suitable for commercial production.

Description

technical field [0001] The invention relates to a pramipexole preparation and a preparation method thereof, belonging to the technical field of chemicals. Background technique [0002] Pramipexole is an anti-Parkinson's disease drug developed by Boehringer Ingelheim in Germany. It is marketed in the form of pramipexole hydrochloride monohydrate. and It was first launched in the United States in July 1997. The dosage forms currently on the market include regular tablets and sustained-release tablets. Among them, the listed specifications of ordinary tablets are: 0.125mg, 0.25mg, 0.5mg, 1.0mg and 1.5mg, and the tablets are packaged in aluminum. [0003] The chemical name of pramipexole is S(-)-2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole. The reported compound forms are pramipexole hydrochloride anhydrate and its monohydrate. The structural formula of the monohydrate is: [0004] [0005] The known marketed form of pramipexole is pramipexole hydrochloride...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/428A61K47/10A61K47/04A61K9/30A61K9/48
Inventor 高慧燕张利峰陈见阳王光强
Owner ZHEJIANG JINGXIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products